Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEDITATE-IVF
2024-515590-10-00Phase 3Authorised
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of Cartia in female infertility (2 arms), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoint: Cumulative live-birth rate. Planned start Jul 2024; status: authorised.
02
Drugs
Cartia
03
Conditions
female infertility
Beyond the preview
Go deeper on 2024-515590-10-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515590-10-00.